160 related articles for article (PubMed ID: 10496939)
1. Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica.
Igwe EI; Rüssmann H; Roggenkamp A; Noll A; Autenrieth IB; Heesemann J
Infect Immun; 1999 Oct; 67(10):5500-7. PubMed ID: 10496939
[TBL] [Abstract][Full Text] [Related]
2. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
Vogel U; Autenrieth IB; Berner R; Heesemann J
Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the course of infection of virulent Yersinia enterocolitica serotype O:8 with an isogenic sodA mutant in the peroral rabbit model.
Najdenski HM; Golkocheva EN; Vesselinova AM; Rüssmann H
Int J Med Microbiol; 2004 Oct; 294(6):383-93. PubMed ID: 15595388
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines.
Di Genaro MS; Waidmann M; Kramer U; Hitziger N; Bohn E; Autenrieth IB
Infect Immun; 2003 Apr; 71(4):1804-12. PubMed ID: 12654794
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the Mn-cofactored superoxide dismutase (SodA) to the virulence of Yersinia enterocolitica serotype O8.
Roggenkamp A; Bittner T; Leitritz L; Sing A; Heesemann J
Infect Immun; 1997 Nov; 65(11):4705-10. PubMed ID: 9353054
[TBL] [Abstract][Full Text] [Related]
6. Virulence, persistence, and immunogenicity of Yersinia enterocolitica O:8 aroA mutants.
Bowe F; O'Gaora P; Maskell D; Cafferkey M; Dougan G
Infect Immun; 1989 Oct; 57(10):3234-6. PubMed ID: 2777382
[TBL] [Abstract][Full Text] [Related]
7. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
8. IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine.
Blanco HM; Lacoste MG; Eliçabe RJ; Di Genaro MS
Vaccine; 2008 Dec; 26(51):6497-502. PubMed ID: 18835575
[TBL] [Abstract][Full Text] [Related]
9. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
10. Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain.
Dave MN; Silva JE; Eliçabe RJ; Jeréz MB; Filippa VP; Gorlino CV; Autenrieth S; Autenrieth IB; Di Genaro MS
Infect Immun; 2016 Nov; 84(11):3172-3181. PubMed ID: 27550935
[TBL] [Abstract][Full Text] [Related]
11. In vivo tracking and protective properties of Yersinia-specific intestinal T cells.
Kempf VA; Bohn E; Noll A; Bielfeldt C; Autenrieth IB
Clin Exp Immunol; 1998 Sep; 113(3):429-37. PubMed ID: 9737673
[TBL] [Abstract][Full Text] [Related]
12. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model.
Trülzsch K; Sporleder T; Igwe EI; Rüssmann H; Heesemann J
Infect Immun; 2004 Sep; 72(9):5227-34. PubMed ID: 15322017
[TBL] [Abstract][Full Text] [Related]
14. Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages.
Roggenkamp A; Leitritz L; Sing A; Kempf VA; Baus K; Heesemann J
Med Microbiol Immunol; 1999 Dec; 188(3):151-9. PubMed ID: 10776846
[TBL] [Abstract][Full Text] [Related]
15. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.
Noll A; Bücheler N; Bohn E; Schirmbeck R; Reimann J; Autenrieth IB
Eur J Immunol; 1999 Mar; 29(3):986-96. PubMed ID: 10092103
[TBL] [Abstract][Full Text] [Related]
16. Interactions between Yersinia enterocolitica and the host with special reference to virulence plasmid encoded adhesion and humoral immunity.
Paerregaard A
Dan Med Bull; 1992 Apr; 39(2):155-72. PubMed ID: 1611921
[TBL] [Abstract][Full Text] [Related]
17. Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats.
Gaede KI; Heesemann J
Infect Immun; 1995 Feb; 63(2):714-9. PubMed ID: 7822048
[TBL] [Abstract][Full Text] [Related]
18. Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice.
Cai K; Zhang Y; Yang B; Chen S
Vaccine; 2013 Jan; 31(2):334-40. PubMed ID: 23153438
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the virulence gene products of Yersinia enterocolitica in the immune response of infected mice.
Takeuchi O; Suzuki T; Kawamura I; Kobayashi N; Takizawa-Hashimoto A; Mitsuyama M
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):321-9. PubMed ID: 16019194
[TBL] [Abstract][Full Text] [Related]
20. Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response.
Autenrieth IB; Vogel U; Preger S; Heymer B; Heesemann J
Infect Immun; 1993 Jun; 61(6):2585-95. PubMed ID: 8500896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
